Wearable Transdermal Drug Applicator With Multi-Modal Permeation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing wearable transdermal drug applicators face challenges in efficiently delivering drugs through the skin, particularly in self-administered therapy, due to limitations in permeation enhancement methods and the use of permeable skin contacting membranes.

Innovation Solution

A wearable transdermal drug applicator is designed with a dock for a liquid drug capsule, a controller, and a permeation enhancing subsystem that includes a sonicator, electrodes, a heater, and red light LEDs to enhance drug delivery through the skin without obstructive membranes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If permeable skin contacting membranes are used to deliver liquid drug, then drug delivery is enabled, but light propagation and heat/sound transmission are obstructed

Engineering Contradiction:
Improvedrug deliveryVSAvoidlight propagation
Core Design Contradiction:
ReliabilityVSIllumination intensity

Solution Approach 1:

The patent removes the permeable membrane component from the system. Instead of using a membrane to deliver liquid drug, the invention employs a liquid reservoir with a liquid-permeable bottom that allows liquid to pass through without requiring a separate permeable membrane, thereby eliminating the obstruction to light and heat/sound transmission

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The bottom of the liquid reservoir serves multiple functions: it contains the liquid drug, allows liquid permeation through its porous structure, and simultaneously permits unobstructed light propagation and heat/sound transmission for the opto-acoustic vaporization process

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If permeable skin contacting membranes are used to deliver liquid drug, then drug delivery is enabled, but heat conductivity and sound transmission are attenuated

Engineering Contradiction:
Improvedrug deliveryVSAvoidheat conductivity
Core Design Contradiction:
ReliabilityVSTemperature

Solution Approach 1:

The patent removes the permeable membrane component that was causing heat conductivity attenuation. The liquid reservoir's porous bottom allows liquid permeation while maintaining unobstructed heat and sound transmission

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention replaces the mechanical membrane-based drug delivery system with an opto-acoustic vaporization system that uses light and sound waves to vaporize and deliver liquid drug through the porous bottom of the reservoir without mechanical barriers

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If multiple permeation enhancing elements are added to enhance transdermal delivery, then drug delivery effectiveness is improved, but device complexity increases

Engineering Contradiction:
Improvetransdermal drug deliveryVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent combines multiple permeation enhancement functions (optical, acoustic, thermal, electrical) into a single integrated wearable device. The opto-acoustic vaporization system merges light propagation, sound transmission, heat generation, and electrical stimulation into one unified mechanism for enhancing transdermal drug delivery

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The wearable device performs multiple functions simultaneously: it stores liquid drug in a reservoir, allows light propagation for opto-acoustic vaporization, transmits sound waves for cavitation effects, generates heat for thermal enhancement, and provides electrical stimulation for iontophoresis, all through a single integrated system

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The described configuration allows for unobstructed operation of permeation enhancing elements, enabling controlled and enhanced transdermal drug delivery, avoiding the limitations of previous technologies and improving the efficiency and effectiveness of self-administered drug therapy.

Implementation Method 1

The elements comprising a sonicator configured to apply ultrasound to skin contacting the dermal contact face for sonophoretic effect to enhance transdermal delivery of the liquid

Methodology Applied
Scientific EffectUltrasound: Ultrasound

Implementation Method 2

The elements further comprise electrodes configured to apply mild electric current to the skin contacting the dermal contact face for iontophoretic effect to enhance transdermal delivery of the liquid

Methodology Applied
Scientific EffectIontophoresis: Iontophoresis

Implementation Method 3

The elements further comprise a heater configured to heat the skin contacting the dermal contact face for vasodilatory and micro-circulation enhancing effect to enhance transdermal drug delivery at the dermal contact face

Methodology Applied
Scientific EffectVasodilation:

Implementation Method 4

The elements further comprise red light LEDs configured to apply red light to the skin contacting the dermal contact face for vasodilatory and micro-circulation enhancing effect to further enhance transdermal drug delivery at the dermal contact face

Methodology Applied
Scientific EffectVasodilation:

Data Source

PatentUS20250050020A1A wearable transdermal drug applicator
Publication Date: 2025.02.13 COSMOAESTHETICS PTY LTD
  • US20250050020A1 patent drawing
  • US20250050020A1 patent drawing
  • US20250050020A1 patent drawing

AI summary

A wearable transdermal drug applicator has a dock for a liquid drug capsule, a dermal contact face, a delivery channel configured for delivering liquid from the drug capsule through a delivery port of the dermal contact face, a controller and a permeation enhancing subsystem interfacing the dermal contact face. The permeation enhancing subsystem has permeation enhancing elements operatively surrounding the delivery port and which are operative to enhance transdermal drug delivery at the dermal contact face. The elements have a sonicator configured to apply ultrasound to skin contacting the dermal contact face, electrodes configured to configured to apply electric current to the skin contacting the dermal contact face, a heater configured to heat the skin contacting the dermal contact face and red light LEDs configured to apply red light to the skin contacting the dermal contact face.